Literature DB >> 30202348

Immunotherapy for Cat Allergies: A Potential Strategy to Scratch Back.

James Clark1, Nicole D White1.   

Abstract

Cat allergies are a common and costly problem in the United States. Various drug and nondrug therapies exist to alleviate and control symptoms once allergic disease has developed. However, these therapies are often ineffective or do not address the underlying condition itself. Immunotherapy is an option for patients when symptoms are not adequately controlled by medications and/or avoidance measures, when adverse effects of medications are unacceptable, or when the patient wants to reduce their long-term use of medication. The purpose of this article is to describe the efficacy and safety of immunotherapy when used to prevent or treat cat allergies.

Entities:  

Keywords:  Felis domesticus allergen 1; allergen-specific immunotherapy; subcutaneous immunotherapy; sublingual immunotherapy

Year:  2017        PMID: 30202348      PMCID: PMC6125099          DOI: 10.1177/1559827617701389

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  27 in total

Review 1.  Scientific foundations of allergen-specific immunotherapy for allergic disease.

Authors:  Michael B Soyka; Willem van de Veen; David Holzmann; Mübeccel Akdis; Cezmi A Akdis
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

2.  Do hypoallergenic cats and dogs exist?

Authors:  Ahmed Butt; Daanish Rashid; Richard F Lockey
Journal:  Ann Allergy Asthma Immunol       Date:  2012-02       Impact factor: 6.347

3.  Childhood cat allergen exposure in three European countries: The AIRALLERG study.

Authors:  Mariëlla Giovannangelo; Ulrike Gehring; Emma Nordling; Marieke Oldenwening; Siegfried de Wind; Tom Bellander; Catarina Almqvist; Joachim Heinrich; Gerard Hoek; Bert Brunekreef
Journal:  Sci Total Environ       Date:  2006-06-06       Impact factor: 7.963

4.  International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis.

Authors:  David Price; Christine Bond; Jacques Bouchard; Rui Costa; Joseph Keenan; Mark L Levy; Mari Orru; Dermot Ryan; Samantha Walker; Margaret Watson
Journal:  Prim Care Respir J       Date:  2005-12-27

5.  Fel d I allergen distribution in cat fur and skin.

Authors:  C Charpin; P Mata; D Charpin; M N Lavaut; C Allasia; D Vervloet
Journal:  J Allergy Clin Immunol       Date:  1991-07       Impact factor: 10.793

6.  Distribution, aerodynamic characteristics, and removal of the major cat allergen Fel d 1 in British homes.

Authors:  A Custovic; A Simpson; H Pahdi; R M Green; M D Chapman; A Woodcock
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

7.  Environmental assessment and exposure control: a practice parameter--furry animals.

Authors:  Jay Portnoy; Kevin Kennedy; James Sublett; Wanda Phipatanakul; Elizabeth Matsui; Charles Barnes; Carl Grimes; J David Miller; James M Seltzer; P Brock Williams; Jonathan A Bernstein; David I Bernstein; Joann Blessing-Moore; Linda Cox; David A Khan; David M Lang; Richard A Nicklas; John Oppenheimer
Journal:  Ann Allergy Asthma Immunol       Date:  2012-04       Impact factor: 6.347

Review 8.  A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.

Authors:  Claus Bachert
Journal:  Clin Ther       Date:  2009-05       Impact factor: 3.393

9.  Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis.

Authors:  K Aasbjerg; C Torp-Pedersen; V Backer
Journal:  Allergy       Date:  2012-09-17       Impact factor: 13.146

10.  Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.

Authors:  J Christian Virchow; Vibeke Backer; Piotr Kuna; Luis Prieto; Hendrik Nolte; Hanne Hedegaard Villesen; Christian Ljørring; Bente Riis; Frederic de Blay
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.